At present, no optimal treatment for these patients has been identified, although radiotherapy has remained a vital treatment.<h4>Case presentation</h4>We experienced a patient with ALK-positive NSCLC who developed brain metastasis after crizotinib therapy. Here, ALK is linked to non-small cell lung carcinoma.